Lessons from First-in-Human Trials for Ultra-Rare Disorders
Lessons from First-in-Human Trials for Ultra-Rare Disorders Key Learnings from First-in-Human Trials in Ultra-Rare Disorders Introduction: The Complexity of First-in-Human Trials First-in-human (FIH) trials mark the critical juncture where laboratory discoveries transition into patient care. For ultra-rare disorders—conditions affecting fewer than 1 in 50,000 people—these trials are uniquely complex. Unlike common diseases where large populations…
Read More “Lessons from First-in-Human Trials for Ultra-Rare Disorders” »